Skip to main content
. 2023 Feb 2;95(2):e28518. doi: 10.1002/jmv.28518

Table 2.

Disproportionality analysis and Bayesian analysis.

N ROR PRR IC EBGM
Drug (95% two‐sided CI) (χ 2) (IC025) (EBGM05)
Infliximab 14 2.14 (1.2, 3.81) 1.95 (7.03) 0.96 (0.54) 1.94 (1.2)
Adalimumab ABC 1.66 (1.49, 1.84) 1.57 (91.54) 0.58 (0.52) 1.5 (1.37)

Abbreviations: CI, confidence interval; EBGM, empirical Bayesian geometric mean; PRR, proportional reporting ratio; ROR, reporting odds ratio.